@ChrissaSJE Distrokid is great except for the double-billing, which I've been subjected to for the last 2 years. I have the credit card statements to prove it but Distrokid denies it. I finally had to report it to the Fraud division of Wells Fargo. Caveat emptor!
@musicben_eth I would advise caution for prospective buyers of Distrokid. I've been getting double-billed for the last 2 years. I have the credit card statements to prove it but Distrokid denies it. I finally had to report it to the Fraud division of Wells Fargo.
We finally have a detailed write-up of our study of NaNots against soluble PD-L1 in a humanized mouse model of cancer @ Mayo Clinic. Efficacy is profound – solely via DEPLETION, no drugs etc. We aim to publish in high-impact journal focused on preclinical innovation. Interested?
@CarlWhi99454847@MayoClinic Hi Carl – NaNots can't do what you propose. NaNots are designed to capture and clear soluble targets in humans and other animals, safely, without disturbing biochemically identical membrane forms of the same molecules. That's a very valuable trick that drugs can't do.
Just released: Video of my presentation at Longevity Summit Dublin 2023, w/ summary of breakthrough @MayoClinic: NaNots profoundly suppressed tumors in humanized mouse models of cancer, just by depleting immune inhibitors from blood!
https://t.co/63SAcHXdI0
NaNotics is delighted to announce new investment from Lifespan Vision Ventures – a new fund focused on the aging and longevity space, including development of next generation therapeutics like NaNots!
https://t.co/ebA8Q1mGHi
#longevity#longevityscience#nanotechnology
I'm excited to present at this great conference alongside some of the longevity researchers I admire most! I'll be presenting our latest results and plans using NaNots – a new class of medicine.
@LEVfoundation@aubreydegrey@martinodea
https://t.co/3NMqNlfLiw just published this interview with me. I'm surprised by how much I like it. Writer @ArkadiMazin managed to draw out of me a coherent tale of my long, strange love affair with science, culminating in the invention of #NaNots. Enjoy! https://t.co/NQWksymEXw
NaNotics to collaborate with Mass General Cancer Center on novel #nanomedicine
Goal is first-in-human use of NaNots, injectable absorptive #nanoparticles that treat #cancer via clearance of tumour-generated immune inhibitors from blood.
@NaNotics
https://t.co/pfvxUeAWgS
@engineers_feed Each triangle, doubled, has an area of 3. The two together = 6. The outer square has an area of (3+1)^2=16. 16-6=10, the area of the blue square.
We are happy to announce Lou Hawthorne, Founder and CEO of @NaNotics LLC, as a speaker for the #RejuvenationStartupSummit 2022.
Lou will speak about NaNots - a new class of medicine under development at NaNotics LLC.
https://t.co/3yjgJADYnq
Many nice comments after my presentation yesterday on NaNots at #ardd2022. One hand I shook belonged to “Emma”, who invited me to attend her lecture today. “Will do,” I said politely. Turns out she’s @EmmaTeeling1 - among the worlds foremost experts on bats! Incredible work!